Vention Medical Acquires RiverTech Medical
DENVER, CO (July 15, 2013) – KRG Capital Partners (KRG) announces that one of its Fund IV platform companies, Vention Medical, a firm that provides an integrated services solution for the design, engineering and manufacturing of complex medical devices and components, has acquired RiverTech Medical. With the acquisition of RiverTech, Vention Medical continues to expand its extensive portfolio of advanced component technology offerings for the development and manufacture of catheter-based devices used in a range of interventional, surgical and minimally invasive procedures. RiverTech’s breadth of experience with polyimide tubing will add to Vention’s current capabilities including balloon catheters, catheter assemblies and a variety of other minimally invasive medical device applications.
RiverTech’s talented team of management shareholders will become shareholders in Vention Medical through the transaction and will continue to lead the RiverTech business post-acquisition.
KRG Capital Partners Fund IV (KRG) made its initial investment in Vention Medical in May of 2008. The acquisition of RiverTech Medical represents the 181st investment for KRG since inception.
About Vention Medical: Vention Medical is an innovative, global medical device solutions partner offering clients more than 30 years of experience in all phases of design, engineering, component manufacturing, and finished device assembly. Vention Medical specializes in components and services used in interventional and minimally invasive surgical products, including medical balloons, catheters, heat shrink tubing, clean room injection molding, finished device assembly and packaging services.
About RiverTech: RiverTech Medical is a leading supplier of polyimide tubing, braided polyimide, composite tubing and wire coatings for numerous medical devices and medical device applications. The Company operates out of Chattanooga, Tennessee.
About KRG Capital Partners: Founded in 1996, KRG is a Denver based private equity buyout firm with $4.4 billion of cumulative capital either deployed or available for future investment, which includes approximately $1.1 billion deployed since inception by institutional equity co-investors. The Firm seeks investment opportunities for its partners where KRG can work in concert with owners and operating managers who are committed to expanding their companies and becoming industry leaders. The result is a partnership that focuses on creating a significantly larger enterprise through a combination of internal growth and complementary add-on acquisitions. Since inception, KRG has invested in 45 platform companies and has completed 136 add-on acquisitions for those platforms. For more information on KRG, please visit www.krgcapital.com.